Prem Pradeep Batchala
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Prem Pradeep Batchala has a total of 111 co-authors. Here are the top co-authors by number of shared publications:
- Sohil H. Patel
Department of Radiology and Medical Imaging, University of Virginia Health System, Charlottesville, USA
7 shared publications Baphiralyne Wankhar
Department of Radiology and Medical Imaging, North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences, Shillong, Meghalaya 793012, India
5 shared publications- Maria Beatriz S Lopes
Department of Pathology, University of Virginia , Charlottesville, VA
5 shared publications - David Schiff
University of Virginia, Charlottesville, VA
4 shared publications Pankaj Nepal
Department of Radiology and Medical Imaging, St. Vincent's Medical Center, Bridgeport, CT, USA
4 shared publications- Rajan Jain
Department of Radiology, New York University Grossman School of Medicine, New York, USA
4 shared publications
Latest Publications
- 30 April 2026
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 101 (9) , 1558-1560
Maxillary Sinus Recirculation Syndrome
- 30 April 2026
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 101 (9) , 1558-1560
Maxillary Sinus Recirculation Syndrome
- 1 July 2025
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 45 (7) , e240107
Surgical Treatment of Medically Refractory Epilepsy and Related Neuroimaging
A broad range of surgical procedures are currently available for patients with medically refractory epilepsy, from open parenchymal resection to minimally invasive ablative and neuromodulatory procedures.
- 1 July 2025
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 45 (7) , e240107
Surgical Treatment of Medically Refractory Epilepsy and Related Neuroimaging
A broad range of surgical procedures are currently available for patients with medically refractory epilepsy, from open parenchymal resection to minimally invasive ablative and neuromodulatory procedures.
- Open Access
- 6 January 2025
- Published by Oxford University Press (OUP) in Neuro-Oncology Advances
- Vol. 7 (1) , vdaf096
Potential synergism of abemaciclib with chloroquine and disulfiram/copper in atypical meningioma: A case report and review of the literature
- 6 January 2025
- Published by Oxford University Press (OUP) in Neuro-Oncology Advances
- Vol. 7 (1) , vdaf096
Open AccessPotential synergism of abemaciclib with chloroquine and disulfiram/copper in atypical meningioma: A case report and review of the literature
- 24 May 2023
- Published by Springer Nature
- p. 1275-1311
Neuroimaging of Brain Tumors in the Era of Radiogenomics
- 24 May 2023
- Published by Springer Nature
- p. 1275-1311
Neuroimaging of Brain Tumors in the Era of Radiogenomics
- 15 May 2023
- Published by Elsevier in Epilepsy & Behavior
- Vol. 143, 109244
Multifocal hypometabolic correlates to deficits of verbal memory in mesial temporal lobe epilepsy
- 15 May 2023
- Published by Elsevier in Epilepsy & Behavior
- Vol. 143, 109244
Multifocal hypometabolic correlates to deficits of verbal memory in mesial temporal lobe epilepsy
- 23 August 2022
- Published by Elsevier in Clinical Imaging
- Vol. 91, 97-104
CT guided injection of 99mTc-MAA for lung nodule localization prior to VATS
- 23 August 2022
- Published by Elsevier in Clinical Imaging
- Vol. 91, 97-104
CT guided injection of 99mTc-MAA for lung nodule localization prior to VATS
- Open Access
- 13 September 2021
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 23 (12) , 1998-1999
Increasing the Scope for 18F-FET PET in Pediatric Neuro-oncology
- 13 September 2021
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 23 (12) , 1998-1999
Open AccessIncreasing the Scope for 18F-FET PET in Pediatric Neuro-oncology
- 1 July 2021
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 30 (7) , 105830
Limiting Brain Shift in Malignant Hemispheric Infarction by Decompressive Craniectomy
- 1 July 2021
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 30 (7) , 105830
Limiting Brain Shift in Malignant Hemispheric Infarction by Decompressive Craniectomy
- 13 April 2021
- Published by Springer Nature in Emergency Radiology
- Vol. 28 (4) , 815-837
Imaging of ureter: a primer for the emergency radiologist
In this review article, we will discuss the gamut of abnormalities involving the ureters. In the emergency department, ureterolithiasis is the most common indication for imaging abdomen and pelvis. However, spectrum of ureteral abnormalities including congenital, infectious and inflammatory, primary and secondary ureteral malignancies, retroperitoneal fibrosis rare described in this article may be encountered. Thus, we will describe acute subacute as well as chronic conditions that may affect ureter. Knowledge of common, as well as rare entities and their imaging features, is of utmost importance to enable appropriate management.
- 13 April 2021
- Published by Springer Nature in Emergency Radiology
- Vol. 28 (4) , 815-837
Imaging of ureter: a primer for the emergency radiologist
In this review article, we will discuss the gamut of abnormalities involving the ureters. In the emergency department, ureterolithiasis is the most common indication for imaging abdomen and pelvis. However, spectrum of ureteral abnormalities including congenital, infectious and inflammatory, primary and secondary ureteral malignancies, retroperitoneal fibrosis rare described in this article may be encountered. Thus, we will describe acute subacute as well as chronic conditions that may affect ureter. Knowledge of common, as well as rare entities and their imaging features, is of utmost importance to enable appropriate management.
- 16 March 2021
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 46 (8) , e438-e439
Papillary Urothelial Carcinoma of Urinary Bladder Identified on 18F-Fluciclovine PET/CT
18F-fluciclovine is a radiolabeled synthetic amino acid recently approved by the Food and Drug Administration for evaluating recurrent prostate cancer. Upregulated amino acid transporters in prostate cancer cells result in elevated radiotracer uptake in sites of tumor recurrence. However, 18F-fluciclovine is not specific for prostate cancer. Nonprostatic malignancies and benign conditions can also demonstrate uptake. This information combined with the knowledge about common patterns of prostate cancer recurrence helps guide appropriate management. We present an 87-year-old man with biochemical recurrence for prostate cancer but found to have a urinary bladder wall mass on 18F-fluciclovine PET/CT with moderate avidity. Biopsy revealed papillary urothelial carcinoma.
- 16 March 2021
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 46 (8) , e438-e439
Papillary Urothelial Carcinoma of Urinary Bladder Identified on 18F-Fluciclovine PET/CT
18F-fluciclovine is a radiolabeled synthetic amino acid recently approved by the Food and Drug Administration for evaluating recurrent prostate cancer. Upregulated amino acid transporters in prostate cancer cells result in elevated radiotracer uptake in sites of tumor recurrence. However, 18F-fluciclovine is not specific for prostate cancer. Nonprostatic malignancies and benign conditions can also demonstrate uptake. This information combined with the knowledge about common patterns of prostate cancer recurrence helps guide appropriate management. We present an 87-year-old man with biochemical recurrence for prostate cancer but found to have a urinary bladder wall mass on 18F-fluciclovine PET/CT with moderate avidity. Biopsy revealed papillary urothelial carcinoma.